As a follow up to my last post on stem cell and PRP injections, I recently came across an article in the New York Times about 12 people who were hospitalized with severe infections after stem cell injections. Read the article here
This is an example of what can happen when an exciting new technology comes along. Some companies and individuals move quickly to capitalize on it, and sometimes the crucial details, like infection control, get lost. And sometimes with disastrous consequences. This is why, in my opinion, it’s best to let a technology prove itself before we try it on our own bodies, rather than get caught up in the enthusiasm of the moment. No one anticipated that this infection problem would develop, and the technology (like many new medical technologies) has been made available to the public before safety protocols are fully worked out. For now, I would steer clear of using what ultimately promises to be very exciting technology.